Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it

Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it

US Patent 6429295 · Granted Aug 6, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants i2025
Fusion proteins composed of an interleukin-2 mutein and type I interferon2024
Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants i2023
Ganglioside GM3-containing nanoparticles as immunomodulators2023
Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 2017
Vaccine composition based on sticholysin encapsulated into liposomes2014
Method for the treatment of malignant and infectious chronic diseases2013
Pharmaceutical compositions capable of inducing apoptosis in tumour cells, usefu2013
Preparations that potentiate immunogenicity in low immunogenic antigens2010
Preparations that potentiate immunogenicity in low immunogenic antigens2010
Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of m2002
Anti ganglioside monoclonal antibodies1998